CymaBay Therapeutics Inc.

NAS: CBAY

GO
/marketstate/country/us

Market open

/zigman2/quotes/201917619/composite

$

4.75

Change

+0.34 +7.60%

Volume

Volume 342,479

Oct 15, 2019, 12:11 p.m.

Real time quotes

/zigman2/quotes/201917619/composite

Previous close

$ 4.41

$ 4.75

Change

+0.34 +7.60%

Day low

Day high

$4.42

$4.75

Open
Open: 4.44

52 week low

52 week high

$4.23

$14.00

Open

Market cap

$302.97M

Average volume

550,670

P/E ratio

N/A

Rev. per Employee

N/A

EPS

-1.39

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/cbay

MarketWatch News on CBAY

  1. CymaBay Therapeutics started at buy with $14 stock price target at Stifel Nicolaus

    7:45 a.m. June 25, 2019

    - Tomi Kilgore

  2. CymaBay Therapeutics stock price target cut to $7 from $11 at B. Riley FBR

    12:15 p.m. June 17, 2019

    - Tomi Kilgore

  3. CymaBay Therapeutics upgraded to strong buy from market outperform at Raymond James

    7:27 a.m. June 12, 2019

    - Tomi Kilgore

  4. CymaBay Therapeutics started at neutral with $9 stock price target at B. Riley FBR

    10:08 a.m. Feb. 6, 2019

    - Tomi Kilgore

  5. CymaBay Therapeutics reiterated as buy at SunTrust Robinson Humphrey

    8:46 a.m. Dec. 31, 2018

    - Ciara Linnane

  6. 4 charts to watch as tech stocks rebound

    12:18 p.m. Feb. 14, 2018

    - Harry Boxer

  7. CymaBay Therapeutics started at outperform with $35 stock price target at Evercore ISI

    8:40 a.m. Feb. 13, 2018

    - Tomi Kilgore

  8. Harry Boxer’s momentum stocks to watch this week

    11:12 a.m. Oct. 25, 2017

    - Harry Boxer

  9. CymaBay Therapeutics started at buy with $15 stock price target at SunTrust RH

    7:35 a.m. Aug. 18, 2017

    - Tomi Kilgore

Analyst Ratings

/news/nonmarketwatch/company/us/cbay

Other News on CBAY

  1. CymaBay presenting two abstracts at Liver Meeting

    4:52 p.m. Oct. 1, 2019

    - Seeking Alpha

  2. 7 Stocks the Insiders Are Buying on Sale

    2:13 p.m. Oct. 1, 2019

    - InvestorPlace.com

  3. Genfit And GenKyoTex In PBC: What To Expect In Phase 3

    5:18 p.m. Aug. 20, 2019

    - Seeking Alpha

  4. CymaBay And Seladelpar In PSC: The Imminent Phase 2 Study

    6:16 p.m. Aug. 16, 2019

    - Seeking Alpha

  5. 10-Q: CYMABAY THERAPEUTICS, INC.

    4:06 p.m. Aug. 7, 2019

    - Edgar Online - (EDG = 10Q, 10K)

  6. Eli Lilly And Baricitinib In PBC: What's The Story?

    3:47 p.m. July 10, 2019

    - Seeking Alpha

  7. Stifel likes Viking Therapeutics in premarket analyst action

    8:25 a.m. June 25, 2019

    - Seeking Alpha

  8. CymaBay +2.8% on new Buy rating at Stifel

    5:20 p.m. June 24, 2019

    - Seeking Alpha

  9. Loading more headlines...
/news/pressrelease/company/us/cbay

Press Releases on CBAY

  1. Tuesday 10/15 Insider Buying Report: CBAY

    10:37 a.m. Today

    - MarketNewsVideo.com

  2. Loading more headlines...

Rates »

Link to MarketWatch's Slice.